Position statements serve as official declarations of an organization’s stance on critical issues affecting a specific field. These statements are grounded in research, expert consensus, and patient advocacy, offering clear guidance on best practices, policy recommendations, and areas in need of improvement.
In the realm of headache and migraine care, position statements play a vital role in shaping healthcare policies, influencing insurance coverage decisions, and ensuring that patients receive appropriate, evidence-based treatment without unnecessary barriers.
The National Headache Foundation supports the American Headache Society’s efforts on behalf of patients and caregivers, advocating for improved access to effective treatments for people living with migraine and other headache disorders.
With advocacy efforts from the migraine community, we are seeing encouraging progress—45% of commercial health plans and pharmacy benefit managers (PBMs) now cover CGRP medications for prevention without step edits, and this is expected to increase to 60% in the coming months.
In alignment with AHS’s position statement, we remain committed to reducing barriers to care, ensuring timely access to evidence-based treatments, and advancing policies that prioritize patient well-being.
To hear how the AHS strives to improve the lives of people impacted by migraine and other headache disorders.